Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Role of Glucagon-Like Peptide 2 in the Treatment of Celiac Disease

EF 2018-19

Résumé
Celiac disease is a common condition in Canadians, and occurs as an immune response of sensitive individuals to ingestion of gluten, a molecule found in wheat. Exposure to gluten in these individuals results in damage to the intestines, resulting in pain and an inability to absorb food that, then, causes diarrhea and (in children), failure to grow normally. Over the past 20 years, we have studied a natural hormone that is produced by the intestines, glucagon-like peptide-2 (GLP-2), which not only causes the intestines to grow but, also, promotes intestinal repair after injury. The aim of the proposed study is to develop a mouse model of celiac disease and to determine whether treatment of these mice with GLP-2 can help prevent intestinal damage and/or promote intestinal repair after damage has been caused by adding gluten to the diet. The long-term goal of these studies is to develop GLP-2 as a novel treatment for patients with severe celiac disease that cannot be prevented by gluten avoidance alone.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406294
Name
Sweeney Maegan E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of Glucagon-Like Peptide 2 in the Treatment of Celiac Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Disorder; Celiac; Glucagon-Like Peptide 2; Gluten; Growth; Inflammation; Intestinal L-Cell; Intestine; Proglucagon-Derived Peptide
Abstract
Celiac disease is a common condition in Canadians, and occurs as an immune response of sensitive individuals to ingestion of gluten, a molecule found in wheat. Exposure to gluten in these individuals results in damage to the intestines, resulting in pain and an inability to absorb food that, then, causes diarrhea and (in children), failure to grow normally. Over the past 20 years, we have studied a natural hormone that is produced by the intestines, glucagon-like peptide-2 (GLP-2), which not only causes the intestines to grow but, also, promotes intestinal repair after injury. The aim of the proposed study is to develop a mouse model of celiac disease and to determine whether treatment of these mice with GLP-2 can help prevent intestinal damage and/or promote intestinal repair after damage has been caused by adding gluten to the diet. The long-term goal of these studies is to develop GLP-2 as a novel treatment for patients with severe celiac disease that cannot be prevented by gluten avoidance alone.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sweeney, Maegan E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~